A Controlled Trial of Androgen Therapy in Experimental Chronic Hypoplastic Marrow Failure
- 1 April 1976
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 32 (4), 533-536
- https://doi.org/10.1111/j.1365-2141.1976.tb00956.x
Abstract
A controlled trial of an androgen, 17-nortestosterone decanoate, was carried out to test its effect as therapy in an experimental model of chronic hypoplastic marrow failure. No effect was detected.Keywords
This publication has 7 references indexed in Scilit:
- A primary stem cell lesion in experimental chronic hypoplastic marrow failureBlood, 1975
- The prognosis in aplastic anemiaBlood, 1975
- HAEMOPOIETIC PRECURSOR CELLS IN EXPERIMENTAL HYPOPLASTIC MARROW FAILUREImmunology & Cell Biology, 1974
- Rapid Stem Cell Differentiation Induced by 19-Nortestosterone DecanoateBritish Journal of Haematology, 1974
- ASSOCIATION OF ANDROGENIC-ANABOLIC STEROID THERAPY WITH DEVELOPMENT OF HEPATOCELLULAR CARCINOMAThe Lancet, 1972
- Aplastic Anaemia, Acute Myeloblastic Leukaemia, and OxymetholoneBMJ, 1971
- Density distribution analysis ofIn vivo andIn vitro colony forming cells in bone marrowJournal of Cellular Physiology, 1970